article thumbnail

CMS finalizes ACA network adequacy rule

Healthcare Dive

Starting in 2026, plans sold in state-based exchanges will be required to meet time and distance standards for provider access that are already applied to plans sold federally.

ACA 196
article thumbnail

Senate Dems reach draft deal to extend ACA premiums, lower drug costs

Healthcare Dive

The bill, part of a more than $300 billion package, extends enhanced ACA premiums and allows Medicare to negotiate select prescription drug prices starting in 2026.

ACA 261
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ACA Health Plans — Key considerations for staying relevant

Innovaare Compliance

A perspective on recent industry shifts influencing ACA plan operations in states, which are yet to adopt ACA Medicaid expansion Health Exchange plans covered under ACA (Accountable Care Act) witnessed 36% enrollment growth between 2021 and 2023. This is the sharpest rise in ACA enrollment since inception. ACA plans).

ACA 52
article thumbnail

Reduced Co-Insurance for Screening Colonoscopies

Medisys Compliance

Section 4104 of the Affordable Care Act (ACA) defined the term ‘preventive services’ to include ‘colorectal cancer screening tests’ and, as a result, it waives any coinsurance that would otherwise apply under Section 1833(a)(1) of the Social Security Act for screening colonoscopies. Background for Reduced Co-Insurance.

article thumbnail

CMS Includes MAOs in Data Exchange and Prior Authorization Requirements

Healthcare Law Blog

Specifically, CMS proposes that, beginning January 1, 2026, impacted payers would be required to: Implement and maintain a FHIR PARDD API using technology conformant with certain standards and implementation specifications in 45 CFR 170.215. CMS is not proposing to apply these requirements to drugs that are covered by the MAO.

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Healthcare Law Blog

The first list of up to 10 Part D negotiation-eligible drugs will be published in 2026, the earliest “price applicability date” at which the Program takes effect. The drug publication date for 2026 will be chosen by September 1, 2023. Additional updates of note include: ACA Premium Tax Credit Eligibility. Other Updates.

article thumbnail

Health Provider News – January 27, 2023

Hall Render

What the state is doing to address the opioid epidemic COVID-19 numbers in decline with latest report Having a baby proves deadlier for Kentucky moms Kentucky flu cases continue to drop in latest report University of Kentucky cardiac, cancer specialists collaborate to prevent heart problems in cancer patients Humana Inc.